Business description
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Management board & Supervisory board
| CEO |
| Paul Hudson |
| Management board |
| Jean-Baptiste Chasseloup de Chatillon, Arnaud Robert, Bill Sibold, Brendan O’Callaghan, Dr. John Reed, Julie Van Ongevalle, Natalie Bickford, Olivier Charmeil, Roy Papatheodorou, Thomas Triomphe |
| Supervisory board |
| Serge Weinberg, Barbara Lavernos, Carole Piwnica, Ceng-Yann Tran, Christophe Babule, Diane Souza, Fabienne Lecorvaisier, Gilles Schnepp, Lise Kingo, Melanie Lee, Patrick Kron, Paul Hudson, Rachel Duan, Thomas Südhof, Wolfgang Laux |
Company data
| Name: |
Sanofi S.A. |
| Address: |
54, Rue La Boétie,F-75008 Paris |
| Phone: |
+33-1-53-77-40-00 |
| Fax: |
+33-1-53-77-43-03 |
| E-mail: |
-
|
| Internet: |
www.sanofi-aventis.com |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12/31 |
| Free Float: |
88.70% |
| IPO date: |
- |